| Summary of Net Revenue, Cost of Sales, Operating Profit, Depreciation and Amortization, Interest Expense and Assets by Segment |
The following table shows, by segment: net revenue, cost of sales, operating profit, depreciation and amortization, interest expense, and assets for the years ended November 30, 2022 and November 30, 2021:
|
|
|
|
|
|
|
|
|
|
|
For the years ended November 30, |
|
|
|
2022 |
|
|
2021 |
|
Net revenue: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
29,771,123 |
|
|
$ |
28,397,401 |
|
PrepaCyte CB |
|
|
104,000 |
|
|
|
111,400 |
|
Public cord blood banking |
|
|
461,626 |
|
|
|
376,101 |
|
Total net revenue |
|
$ |
30,336,749 |
|
|
$ |
28,884,902 |
|
Cost of sales: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
7,095,113 |
|
|
$ |
7,351,410 |
|
PrepaCyte CB |
|
|
100,715 |
|
|
|
154,140 |
|
Public cord blood banking |
|
|
1,596,530 |
|
|
|
1,484,186 |
|
Total cost of sales |
|
$ |
8,792,358 |
|
|
$ |
8,989,736 |
|
Operating profit: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
5,185,305 |
|
|
$ |
6,362,172 |
|
PrepaCyte CB |
|
|
(24,493 |
) |
|
|
(70,335 |
) |
Public cord blood banking |
|
|
(1,136,345 |
) |
|
|
(2,273,604 |
) |
Total operating profit |
|
$ |
4,024,467 |
|
|
$ |
4,018,233 |
|
Depreciation and amortization: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
1,090,309 |
|
|
$ |
806,230 |
|
PrepaCyte CB |
|
|
27,778 |
|
|
|
27,595 |
|
Public cord blood banking |
|
|
1,441 |
|
|
|
1,020 |
|
Total depreciation and amortization |
|
$ |
1,119,528 |
|
|
$ |
834,845 |
|
Interest expense: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
1,521,767 |
|
|
$ |
1,378,926 |
|
PrepaCyte CB |
|
|
— |
|
|
|
— |
|
Public cord blood banking |
|
|
— |
|
|
|
— |
|
Total interest expense |
|
$ |
1,521,767 |
|
|
$ |
1,378,926 |
|
|
|
|
|
|
|
|
The following table shows the assets by segment as of November 30, 2022 and November 30, 2021:
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
|
2021 |
|
Assets: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell
service |
|
$ |
54,849,697 |
|
|
$ |
50,170,887 |
|
PrepaCyte CB |
|
|
176,546 |
|
|
|
250,591 |
|
Public cord blood banking |
|
|
9,861,811 |
|
|
|
10,240,598 |
|
Total assets |
|
$ |
64,888,054 |
|
|
$ |
60,662,076 |
|
|